I hope they're successful in ultimately lowering the checkpoint inhibitor costs. Obviously they're motivated by market share, but there is an altruistic bent that will convince them to carry on and not get gobbled up by a big pharma firm.
Has been lagging quite poorly of late but hopefully once the company releases the entire data set with durability of response, this should see an uptick in share price!
Update results were great! Next step approval. 🤞
Fda Approved 🎉
It is now time to boom! 28.dec.2024 watch out CKPT!
Very promising company. Lots of potential.
I hope they're successful in ultimately lowering the checkpoint inhibitor costs. Obviously they're motivated by market share, but there is an altruistic bent that will convince them to carry on and not get gobbled up by a big pharma firm.
Thank You!
Has been lagging quite poorly of late but hopefully once the company releases the entire data set with durability of response, this should see an uptick in share price!
Long CKPT
Interesting but when is data coming out
Q4-2021 - Cosibelimab P3
TBD - CK101 in NSCLC
Thoughts on SQZ Biotech?
⭐⭐⭐⭐⭐